{"id":31920,"date":"2026-09-02T01:40:10","date_gmt":"2026-09-01T16:40:10","guid":{"rendered":"https:\/\/uhcell.com\/skin-boosters-or-exosomes-which-builds-real-glass-skin\/"},"modified":"2026-09-02T01:40:17","modified_gmt":"2026-09-01T16:40:17","slug":"skin-boosters-or-exosomes-which-builds-real-glass-skin","status":"publish","type":"post","link":"https:\/\/uhcell.com\/en\/skin-boosters-or-exosomes-which-builds-real-glass-skin\/","title":{"rendered":"Skin Boosters or Exosomes: Which Builds Real Glass Skin?"},"content":{"rendered":"<p><script type=\"application\/ld+json\">[{\"@context\":\"https:\/\/schema.org\",\"@type\":\"Article\",\"headline\":\"Skin Boosters or Exosomes: Which Builds Real Glass Skin?\",\"description\":\"Glass skin depends on hydration and texture more than any specific injectable. Skin boosters carry controlled trial data; exosomes still lack Korean drug approval.\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\/\/aiamptvenyoentppdreg.supabase.co\/storage\/v1\/object\/public\/domain-thumbnails\/c749ffcd-e12e-4d15-a5a7-10e65eff079d\/gallery-eba0765e-4669-4f50-a01d-01880ccf498b.jpg\"},\"url\":\"https:\/\/uhcell.com\/en\/skin-boosters-or-exosomes-which-builds-real-glass-skin\/\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/uhcell.com\/en\/skin-boosters-or-exosomes-which-builds-real-glass-skin\/\"},\"articleSection\":\"comparison\",\"keywords\":\"skin booster vs exosome, glass skin Korea, Rejuran Skinvive comparison, exosome treatment regulation Korea\",\"wordCount\":2166,\"inLanguage\":\"en\",\"datePublished\":\"2026-09-01T16:40:12.769Z\",\"dateModified\":\"2026-09-01T16:40:12.769Z\",\"dateCreated\":\"2026-09-01T16:40:12.769Z\",\"author\":{\"@type\":\"Organization\",\"name\":\"UH CELL Clinic\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"UH CELL Clinic\",\"url\":\"https:\/\/uhcell.com\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\/\/www.google.com\/s2\/favicons?domain=uhcell.com&sz=32\"}}},{\"@context\":\"https:\/\/schema.org\",\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"UH CELL Clinic\",\"item\":\"https:\/\/uhcell.com\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Skin Boosters or Exosomes: Which Builds Real Glass Skin?\",\"item\":\"https:\/\/uhcell.com\/en\/skin-boosters-or-exosomes-which-builds-real-glass-skin\/\"}]},{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Can I get a skin booster and an exosome treatment in the same visit?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Most of the published human research on exosomes actually studies this exact combination. Whether it's available at our clinic depends on the specific product's regulatory registration and how it's meant to be delivered. We confirm that in consultation and don't offer combinations that fall outside approved use.\"}},{\"@type\":\"Question\",\"name\":\"How long does a skin booster actually last?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Skinvive pivotal trial reported results through six months, with 56% of patients still showing at least a one-point improvement on the cheek smoothness scale at that point. Polynucleotide boosters are typically delivered across multiple sessions rather than as a single treatment, and the 66-patient real-world study measuring PN use collected data across three sessions. Individual results vary with skin condition and lifestyle.\"}},{\"@type\":\"Question\",\"name\":\"Is it safe to fly the day after a booster injection?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Flying with residual swelling from a dermal injection can feel worse in a dry cabin environment. We generally recommend at least one full day between an injection and a long flight. If the schedule is tight, we adjust the strength and area of the treatment to fit it.\"}},{\"@type\":\"Question\",\"name\":\"What should I ask if a clinic brings up exosomes?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Ask two things: what regulatory category the specific product is registered under, and whether it reaches the skin by injection or by topical application. The Seoul Administrative Court's 2025 ruling addressed exactly the combination of a topical-registered product delivered by injection. Clear answers to both questions are the starting point.\"}},{\"@type\":\"Question\",\"name\":\"Does the treatment plan change for male patients?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sebum production and dermal thickness differ, so injection volume and depth get adjusted. The sequence stays the same: diagnose first, separate the target categories, then build the combination.\\n\\n---\\n\\nIf glass skin is the goal, start with what your skin is actually missing rather than the name of a treatment. Consultations and treatment planning can be booked through [our Seocho clinic](https:\/\/uhcell.com\/en).\"}}]},{\"@context\":\"https:\/\/schema.org\",\"@type\":\"ItemList\",\"name\":\"Skin Boosters or Exosomes: Which Builds Real Glass Skin?\",\"description\":\"Glass skin depends on hydration and texture more than any specific injectable. Skin boosters carry controlled trial data; exosomes still lack Korean drug approval.\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"What \\\"Glass Skin\\\" Means on an Exam Chart\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hyaluronic Acid Boosters: The Trial Data Is Public\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Polynucleotide Boosters: A Slower Way to Hold Water\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Where Exosomes Currently Sit in Practice\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"The Regulatory Line We Watch in Korea\"},{\"@type\":\"ListItem\",\"position\":6,\"name\":\"Evidence and Regulatory Status Side by Side\"},{\"@type\":\"ListItem\",\"position\":7,\"name\":\"How We Sequence It for Patients at Our Seocho Clinic\"},{\"@type\":\"ListItem\",\"position\":8,\"name\":\"What Actually Trips Up a Short Stay\"}]}]<\/script><\/p>\n<blockquote>\n<p><strong>TL;DR:<\/strong> Glass skin depends on how much water the dermis holds and how evenly the surface reflects light, not on which injectable trend is newest. Hyaluronic acid and polynucleotide skin boosters go directly into the dermis and carry controlled clinical trial data behind them. Exosomes have no approved human injectable drug product in Korea, so when they show up in a treatment plan they are almost always a topical add-on layered onto a device procedure, not a standalone injection.<\/p>\n<\/blockquote>\n<p>I&#8217;m Dr. Kim Kyungsoo, director at our Seocho clinic. When a patient asks whether a hydrating injection or an exosome serum gets them closer to glass skin, I start by separating the two into categories before I talk about either one by brand name. One is placed directly into the dermis with a needle. The other is usually brushed onto skin that a device, most often a microneedling pass, has already opened. The evidence base is not the same size for both, and in Korea the legal status is not the same either.<\/p>\n<h2>What &#8220;Glass Skin&#8221; Means on an Exam Chart<\/h2>\n<p>Patients use &#8220;glass skin&#8221; to describe three separate things at once, and that mix-up is where mismatched expectations start. The first is water content in the stratum corneum and dermis. The second is surface texture: how evenly a face reflects light once pores and roughness are accounted for. The third is tone uniformity, meaning whether redness or pigment breaks up an otherwise even color.<\/p>\n<p>Each of those three responds to a different intervention. A dermis short on water responds to hyaluronic acid placed where the water is missing. A rough surface with visible pores needs a treatment that encourages collagen to reorganize, which takes longer than a single injection. Pigment problems do not resolve with either of the first two. When a patient expects one procedure to fix all three, the result often reads as underwhelming even when the treatment did exactly what it was designed to do.<\/p>\n<h2>Hyaluronic Acid Boosters: The Trial Data Is Public<\/h2>\n<p>A 2024 survey of Korean dermatologists published in the Journal of Cosmetic Dermatology defines skin boosters as injectable products aimed at improving texture, elasticity, hydration, and overall skin appearance, a different goal from the volume that fillers add.<\/p>\n<p>Skinvive by Juv\u00e9derm, a hyaluronic acid gel delivered as intradermal microdroplets, received FDA approval in May 2023 to improve cheek skin smoothness in adults 21 and older. In the randomized, multicenter, evaluator-blinded pivotal trial behind that approval, 58% of patients (73 of 125) showed at least a one-point improvement on the Allergan Cheek Smoothness Scale at one month, and 56% (69 of 124) still showed it at six months. On a separate satisfaction survey, the share of patients satisfied with how radiant their skin looked rose from 11% before treatment to 63% at six months, and satisfaction with hydration rose from 24% to 72% over the same period.<\/p>\n<p>Macrene Alexiades, MD, PhD, the trial&#8217;s lead investigator, told Pharmacy Times that skin quality is one of the concerns patients raise most often when they come in for aesthetic treatment.<\/p>\n<p>Read plainly, those numbers describe roughly half of patients under evaluator-blinded conditions. I share them with patients exactly as published, because a booster that performs well on paper but is oversold on expectations tends to leave people disappointed even after a technically successful treatment.<\/p>\n<h2>Polynucleotide Boosters: A Slower Way to Hold Water<\/h2>\n<p>Rejuran and similar polynucleotide (PN) products are highly purified, long-chain DNA fragments, typically derived from fish, injected into the dermis. A 2026 expert review in Clinical, Cosmetic and Investigational Dermatology describes PN as hydrophilic, meaning it draws water into the tissue, and links that mechanism to gains in elasticity and texture, reduced fine lines, and less dryness. The same review reports that PN tends to be tolerated better than hyaluronic acid or collagen-stimulating boosters, with most reactions limited to swelling, mild discomfort, or bruising at the injection site.<\/p>\n<p>A 2026 real-world observational study in the Journal of Cosmetic Dermatology followed 66 adults who received three intradermal sessions of high-purity PN across the face, neck, and d\u00e9colletage. It had no control arm and relied on patient-reported outcomes, so it says more about how PN is actually used in practice, staged across multiple sessions, than about a precise effect size.<\/p>\n<p>The practical difference between the two booster types is timing. Hyaluronic acid holds the water it arrives with almost immediately. PN changes how the dermis behaves over weeks. That is why I plan it around a patient&#8217;s calendar rather than a single appointment.<\/p>\n<h2>Where Exosomes Currently Sit in Practice<\/h2>\n<p>Exosomes are nanoscale vesicles that cells release to carry proteins and signaling molecules such as microRNA to other cells. The mechanism reads well on paper.<\/p>\n<p>Human data exists, but it comes with a structural limitation. A 2023 randomized split-face trial by Park and colleagues, summarized in a Skin Health and Disease review, enrolled 28 patients and compared microneedling alone against microneedling combined with a solution containing human adipose stem cell-derived exosomes. At 12 weeks, the combination side showed larger improvements across every measure: wrinkle reduction of 13.4% versus 7.1%, an elasticity gain of 11.3% versus a 3.3% decline, hydration gain of 6.5% versus 4.5%, and melanin reduction of 9.9% versus 1%.<\/p>\n<p>The design does not separate how much of that improvement came from the exosome solution and how much came from the microneedling device, since every patient in the exosome arm also received microneedling. A systematic review and meta-analysis in Aesthetic Surgery Journal, searching literature through February 2025, identified 39 human studies, 26 on skin and 13 on hair, and most shared this same combined design.<\/p>\n<p>A 2025 review in the Journal of Drugs in Dermatology summarized the state of exosome evidence in cosmetic use as largely preclinical or early-stage, citing inconsistent isolation and characterization methods across studies and unresolved questions about potency and safety tied to differing source material. The same review confirmed that no exosome product currently holds FDA approval for cosmetic use.<\/p>\n<h2>The Regulatory Line We Watch in Korea<\/h2>\n<p>This matters more for international patients than almost anything else in this comparison, because it is the hardest thing to verify from abroad. No exosome product is currently approved in Korea as a drug for human injection, a category regulators classify as a cell-derived vesicle therapeutic. Most exosome products sold in the Korean market are registered as topical cosmetics.<\/p>\n<p>That distinction has already produced a disciplinary case. On April 11, 2025, the Seoul Administrative Court upheld a three-month license suspension the Ministry of Health and Welfare issued to a physician who injected a cosmetics-registered exosome product into a patient&#8217;s face. The Ministry&#8217;s position was that a product approved for topical use becomes a drug once it is delivered by injection, and the court found the act constituted unethical medical practice under Korea&#8217;s Medical Service Act.<\/p>\n<p>Advertising rules moved the same direction. In January 2025, the Ministry of Food and Drug Safety revised its cosmetic labeling and advertising guidelines to add banned expressions, including human-derived ingredient claims like &#8220;exosome cosmetics,&#8221; terms implying medical specialist endorsement such as &#8220;hospital-exclusive&#8221; or &#8220;for dermatology use,&#8221; and the word &#8220;microneedle&#8221; when it could mislead patients about how a product is meant to be used.<\/p>\n<p>Two questions cover most of what a patient needs to check when exosomes come up in a consultation: what regulatory category the product is registered under, and whether it reaches the skin by injection or by application. A topical-registered product delivered by injection sits inside the exact territory the 2025 ruling addressed. We do not build recovery protocols around that combination.<\/p>\n<h2>Evidence and Regulatory Status Side by Side<\/h2>\n<table>\n<thead>\n<tr>\n<th>Category<\/th>\n<th>HA and PN skin boosters<\/th>\n<th>Exosomes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>How they reach skin<\/td>\n<td>Direct intradermal injection<\/td>\n<td>Usually applied after a device procedure, often paired with topical delivery<\/td>\n<\/tr>\n<tr>\n<td>Primary target<\/td>\n<td>Hydration, smoothness, elasticity<\/td>\n<td>Combined improvement in wrinkles, pigment, and texture<\/td>\n<\/tr>\n<tr>\n<td>Controlled human data<\/td>\n<td>Evaluator-blinded randomized pivotal trial (Skinvive)<\/td>\n<td>Split-face comparison exists, mostly within combined-treatment designs<\/td>\n<\/tr>\n<tr>\n<td>Cosmetic-use approval status<\/td>\n<td>Skinvive FDA-approved for cheek smoothness (2023)<\/td>\n<td>No FDA-approved cosmetic product (JDD, 2025)<\/td>\n<\/tr>\n<tr>\n<td>Korean regulatory status<\/td>\n<td>Approved drug or device products in clinical use<\/td>\n<td>No approved human-injectable exosome drug; most products registered as cosmetics<\/td>\n<\/tr>\n<tr>\n<td>Evidence maturity<\/td>\n<td>Pivotal trial data plus accumulating real-world use<\/td>\n<td>Early-stage, inconsistent isolation methods across studies<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For a glass skin goal specifically, the category with more mature verification right now is the injectable booster. Exosomes show promising signals in combination studies, but the evidence and the Korean regulatory record have not caught up to a standalone claim yet.<\/p>\n<h2>How We Sequence It for Patients at Our Seocho Clinic<\/h2>\n<p>I start with a diagnosis before naming any procedure.<\/p>\n<p>First, we separate the skin into the three measurable categories above: hydration, texture, and tone. Most patients have some degree of all three, and deciding which one to address first changes the outcome more than the choice of device or injectable does.<\/p>\n<p>Second, we check the calendar. Around 90% of our patients travel from outside Korea, and most stay between two and seven days. A five-day stay supports a different combination than a two-day stay, even when the underlying skin goal is identical.<\/p>\n<p>Third, we build the combination. If hydration and smoothness are the priority and the trip is short, a hyaluronic acid booster alone is often enough. If the goal is improvement over several months, we stage polynucleotide sessions instead. If texture and firmness both need work, we build the plan around a radiofrequency microneedling device and place the injectable afterward. The same clinician carries a patient from diagnosis through design to the procedure itself.<\/p>\n<p>Fourth, we plan the recovery window as carefully as the injection itself. Any procedure that puts a needle into the dermis needs time for the micro-channels to close. Makeup timing for each treatment category is covered in <a aria-label=\"Go to UH CELL home\" href=\"https:\/\/uhcell.com\/en\/when-can-you-wear-makeup-after-a-skin-procedure-in-seoul\/\">our recovery guide for skin procedures in Seoul<\/a>.<\/p>\n<h2>What Actually Trips Up a Short Stay<\/h2>\n<p>Swelling and small injection marks from booster treatments usually settle within one to three days. Where that window gets spent matters more than the swelling itself. Long transit and repeated sun exposure stretch the same recovery period longer than it needs to be.<\/p>\n<p>Our Seocho clinic sits inside the UH FLAT The Seocho hotel building rather than operating as a separate partner clinic somewhere else. A patient can move from treatment room to guest room without leaving the building. Hotel guests receive a complimentary oxygen chamber session and vitamin IV drip. Procedures happen in private treatment rooms, and Japanese, Chinese, and English interpreters are on site.<\/p>\n<p>If a patient wants to narrow down candidate treatments before flying in, <a aria-label=\"Go to UH CELL home\" href=\"https:\/\/uhcell.com\/en\/how-far-can-a-pre-trip-video-consult-with-a-skin-clinic-go\/\">our guide to pre-trip video consultations<\/a> covers what a remote consultation can and cannot decide. Photos and a written history can narrow the list. A confirmed treatment plan still needs an in-person exam.<\/p>\n<h2>FAQ<\/h2>\n<h3>Can I get a skin booster and an exosome treatment in the same visit?<\/h3>\n<p>Most of the published human research on exosomes actually studies this exact combination. Whether it&#8217;s available at our clinic depends on the specific product&#8217;s regulatory registration and how it&#8217;s meant to be delivered. We confirm that in consultation and don&#8217;t offer combinations that fall outside approved use.<\/p>\n<h3>How long does a skin booster actually last?<\/h3>\n<p>The Skinvive pivotal trial reported results through six months, with 56% of patients still showing at least a one-point improvement on the cheek smoothness scale at that point. Polynucleotide boosters are typically delivered across multiple sessions rather than as a single treatment, and the 66-patient real-world study measuring PN use collected data across three sessions. Individual results vary with skin condition and lifestyle.<\/p>\n<h3>Is it safe to fly the day after a booster injection?<\/h3>\n<p>Flying with residual swelling from a dermal injection can feel worse in a dry cabin environment. We generally recommend at least one full day between an injection and a long flight. If the schedule is tight, we adjust the strength and area of the treatment to fit it.<\/p>\n<h3>What should I ask if a clinic brings up exosomes?<\/h3>\n<p>Ask two things: what regulatory category the specific product is registered under, and whether it reaches the skin by injection or by topical application. The Seoul Administrative Court&#8217;s 2025 ruling addressed exactly the combination of a topical-registered product delivered by injection. Clear answers to both questions are the starting point.<\/p>\n<h3>Does the treatment plan change for male patients?<\/h3>\n<p>Sebum production and dermal thickness differ, so injection volume and depth get adjusted. The sequence stays the same: diagnose first, separate the target categories, then build the combination.<\/p>\n<hr \/>\n<p>If glass skin is the goal, start with what your skin is actually missing rather than the name of a treatment. Consultations and treatment planning can be booked through <a aria-label=\"Go to UH CELL home\" href=\"https:\/\/uhcell.com\/en\">our Seocho clinic<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glass skin depends on hydration and texture more than any specific injectable. Skin boosters carry controlled trial data; exosomes still lack Korean drug approval.<\/p>\n","protected":false},"author":2,"featured_media":31916,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","ai_generated_summary":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[551],"tags":[],"class_list":["post-31920","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-skin-booster"],"acf":[],"taxonomy_info":{"category":[{"value":551,"label":"Skin Booster Treatment"}]},"featured_image_src_large":["https:\/\/uhcell.com\/wp-content\/uploads\/2026\/09\/cover-c72da0c6-1024x576.webp",1024,576,true],"author_info":{"display_name":"\uae40\uc5f0\uc9c4 \ub300\ud45c\uc6d0\uc7a5","author_link":"https:\/\/uhcell.com\/en\/author\/uhcell_gangnam\/"},"comment_info":"","category_info":[{"term_id":551,"name":"Skin Booster Treatment","slug":"skin-booster","term_group":0,"term_taxonomy_id":551,"taxonomy":"category","description":"","parent":0,"count":18,"filter":"raw","cat_ID":551,"category_count":18,"category_description":"","cat_name":"Skin Booster Treatment","category_nicename":"skin-booster","category_parent":0}],"tag_info":false,"uhcell_seo_meta":{"rank_math_title":"","rank_math_description":"","rank_math_facebook_title":"","rank_math_facebook_description":"","rank_math_twitter_title":"","rank_math_twitter_description":"","rank_math_twitter_card_type":"","og_title":null,"og_description":null},"wpml":{"trid":19443,"language_code":"en","source_language_code":"ko","element_type":"post_post","translations":{"cn":{"id":31928,"lang":"cn","title":"\u8865\u6c34\u9488\u548c\u5916\u6ccc\u4f53\u600e\u4e48\u9009\uff1f\u6c5f\u5357\u76ae\u80a4\u79d1\u533b\u751f\u89e3\u6790\u6c34\u5149\u808c\u65b9\u6848","slug":"%e8%a1%a5%e6%b0%b4%e9%92%88%e5%92%8c%e5%a4%96%e6%b3%8c%e4%bd%93%e6%80%8e%e4%b9%88%e9%80%89%ef%bc%9f%e6%b1%9f%e5%8d%97%e7%9a%ae%e8%82%a4%e7%a7%91%e5%8c%bb%e7%94%9f%e8%a7%a3%e6%9e%90%e6%b0%b4%e5%85%89","url":"https:\/\/uhcell.com\/cn\/%e8%a1%a5%e6%b0%b4%e9%92%88%e5%92%8c%e5%a4%96%e6%b3%8c%e4%bd%93%e6%80%8e%e4%b9%88%e9%80%89%ef%bc%9f%e6%b1%9f%e5%8d%97%e7%9a%ae%e8%82%a4%e7%a7%91%e5%8c%bb%e7%94%9f%e8%a7%a3%e6%9e%90%e6%b0%b4%e5%85%89\/","status":"publish","original":false},"en":{"id":31920,"lang":"en","title":"Skin Boosters or Exosomes: Which Builds Real Glass Skin?","slug":"skin-boosters-or-exosomes-which-builds-real-glass-skin","url":"https:\/\/uhcell.com\/en\/skin-boosters-or-exosomes-which-builds-real-glass-skin\/","status":"publish","original":false},"ja":{"id":31924,"lang":"ja","title":"\u6c34\u5149\u808c\u3092\u76ee\u6307\u3059\u65bd\u8853\u9078\u3073\u3001\u30b9\u30ad\u30f3\u30d6\u30fc\u30b9\u30bf\u30fc\u3068\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u306e\u9055\u3044\u3068\u306f","slug":"%e6%b0%b4%e5%85%89%e8%82%8c%e3%82%92%e7%9b%ae%e6%8c%87%e3%81%99%e6%96%bd%e8%a1%93%e9%81%b8%e3%81%b3%e3%80%81%e3%82%b9%e3%82%ad%e3%83%b3%e3%83%96%e3%83%bc%e3%82%b9%e3%82%bf%e3%83%bc%e3%81%a8%e3%82%a8","url":"https:\/\/uhcell.com\/ja\/%e6%b0%b4%e5%85%89%e8%82%8c%e3%82%92%e7%9b%ae%e6%8c%87%e3%81%99%e6%96%bd%e8%a1%93%e9%81%b8%e3%81%b3%e3%80%81%e3%82%b9%e3%82%ad%e3%83%b3%e3%83%96%e3%83%bc%e3%82%b9%e3%82%bf%e3%83%bc%e3%81%a8%e3%82%a8\/","status":"publish","original":false},"ko":{"id":31917,"lang":"ko","title":"\uc2a4\ud0a8\ubd80\uc2a4\ud130\uc640 \uc5d1\uc18c\uc880, \ubb3c\uad11 \ud53c\ubd80\uc5d4 \uc5b4\ub290 \ucabd\uc77c\uae4c","slug":"%ec%8a%a4%ed%82%a8%eb%b6%80%ec%8a%a4%ed%84%b0%ec%99%80-%ec%97%91%ec%86%8c%ec%a2%80-%eb%ac%bc%ea%b4%91-%ed%94%bc%eb%b6%80%ec%97%94-%ec%96%b4%eb%8a%90-%ec%aa%bd%ec%9d%bc%ea%b9%8c","url":"https:\/\/uhcell.com\/%ec%8a%a4%ed%82%a8%eb%b6%80%ec%8a%a4%ed%84%b0%ec%99%80-%ec%97%91%ec%86%8c%ec%a2%80-%eb%ac%bc%ea%b4%91-%ed%94%bc%eb%b6%80%ec%97%94-%ec%96%b4%eb%8a%90-%ec%aa%bd%ec%9d%bc%ea%b9%8c\/","status":"publish","original":true},"tw":{"id":31931,"lang":"tw","title":"\u6c34\u5149\u808c\u600e\u9ebc\u9078?\u6c34\u5149\u91dd\u8207\u5916\u6ccc\u9ad4\u7684\u5be6\u8b49\u7b49\u7d1a\u5dee\u5728\u54ea","slug":"%e6%b0%b4%e5%85%89%e8%82%8c%e6%80%8e%e9%ba%bc%e9%81%b8%e6%b0%b4%e5%85%89%e9%87%9d%e8%88%87%e5%a4%96%e6%b3%8c%e9%ab%94%e7%9a%84%e5%af%a6%e8%ad%89%e7%ad%89%e7%b4%9a%e5%b7%ae%e5%9c%a8%e5%93%aa","url":"https:\/\/uhcell.com\/tw\/%e6%b0%b4%e5%85%89%e8%82%8c%e6%80%8e%e9%ba%bc%e9%81%b8%e6%b0%b4%e5%85%89%e9%87%9d%e8%88%87%e5%a4%96%e6%b3%8c%e9%ab%94%e7%9a%84%e5%af%a6%e8%ad%89%e7%ad%89%e7%b4%9a%e5%b7%ae%e5%9c%a8%e5%93%aa\/","status":"publish","original":false}}},"_links":{"self":[{"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/posts\/31920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/comments?post=31920"}],"version-history":[{"count":1,"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/posts\/31920\/revisions"}],"predecessor-version":[{"id":31921,"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/posts\/31920\/revisions\/31921"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/media\/31916"}],"wp:attachment":[{"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/media?parent=31920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/categories?post=31920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/uhcell.com\/en\/wp-json\/wp\/v2\/tags?post=31920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}